Mutation analysis of MLH1 and MSH2 genes performed by denaturing high-performance liquid chromatography

被引:45
|
作者
Kurzawski, G
Safranow, K
Suchy, J
Chlubek, D
Scott, RJ
Lubinski, J
机构
[1] Pomeranian Acad Med, Dept Genet & Pathol, Hereditary Canc Ctr, PL-70115 Szczecin, Poland
[2] Pomeranian Acad Med, Dept Chem & Biochem, PL-70115 Szczecin, Poland
[3] Univ Newcastle, Discipline Med Genet, Newcastle, NSW 2308, Australia
来源
JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS | 2002年 / 51卷 / 01期
关键词
DHPLC; MLH1; MSH2; mutation analysis; colorectal cancer; Lynch syndrome; hereditary nonpolyposis colorectal cancer (HNPCC);
D O I
10.1016/S0165-022X(02)00003-9
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Mutation analysis of large genes, such as MSH2 and MLH1, is time-consuming and expensive. We investigated the sensitivity and specificity of DHPLC analysis for the detection of mutations within both MSH2 and MLH1. Studies included a series of 46 patients affected by colorectal cancer from UNPCC families. We confirmed 19 changes previously identified by DNA sequencing and, in a blind study, an additional 16 rare alterations including four mutations not previously described. Generally, false negative results were not observed. Elution profiles were highly characteristic for a given change and in 98.5% cases allowed the distinction between novel alterations and previously identified mutations and polymorphisms. For the detection of changes in almost all amplicons, it was sufficient to use just one denaturing temperature. DHPLC was confirmed to be highly sensitive, specific and a cost-effective technique with particularly high potential for the detection of MSH2 and MLH1 gene mutations in the diagnostic setting. Crown Copyright (C) 2002 Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:89 / 100
页数:12
相关论文
共 50 条
  • [1] Cancer Risks for MLH1 and MSH2 Mutation Carriers
    Dowty, James G.
    Win, Aung K.
    Buchanan, Daniel D.
    Lindor, Noralane M.
    Macrae, Finlay A.
    Clendenning, Mark
    Antill, Yoland C.
    Thibodeau, Stephen N.
    Casey, Graham
    Gallinger, Steve
    Le Marchand, Loic
    Newcomb, Polly A.
    Haile, Robert W.
    Young, Graeme P.
    James, Paul A.
    Giles, Graham G.
    Gunawardena, Shanaka R.
    Leggett, Barbara A.
    Gattas, Michael
    Boussioutas, Alex
    Ahnen, Dennis J.
    Baron, John A.
    Parry, Susan
    Goldblatt, Jack
    Young, Joanne P.
    Hopper, John L.
    Jenkins, Mark A.
    HUMAN MUTATION, 2013, 34 (03) : 490 - 497
  • [2] Germline mutation analysis of MLH1 and MSH2 in Malaysian Lynch syndrome patients
    Mohd Nizam Zahary
    Gurjeet Kaur
    Muhammad Radzi Abu Hassan
    Harjinder Singh
    Venkatesh R Naik
    Ravindran Ankathil
    World Journal of Gastroenterology, 2012, (08) : 814 - 820
  • [3] Germline mutation analysis of MLH1 and MSH2 in Malaysian Lynch syndrome patients
    Zahary, Mohd Nizam
    Kaur, Gurjeet
    Abu Hassan, Muhammad Radzi
    Singh, Harjinder
    Naik, Venkatesh R.
    Ankathil, Ravindran
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (08) : 814 - 820
  • [4] Expressional analysis of MLH1 and MSH2 in breast cancer
    Malik, Saima Shakil
    Masood, Nosheen
    Asif, Muhammad
    Ahmed, Parvez
    Shah, Zafar Ullah
    Khan, Jahangir Sarwar
    CURRENT PROBLEMS IN CANCER, 2019, 43 (02) : 97 - 105
  • [5] A comparison of models used to predict MLH1, MSH2 and MSH6 mutation carriers
    Pouchet, C. J.
    Wong, N.
    Chong, G.
    Sheehan, M. J.
    Schneider, G.
    Rosen-Sheidley, B.
    Foulkes, W.
    Tischkowitz, M.
    ANNALS OF ONCOLOGY, 2009, 20 (04) : 681 - 688
  • [6] Tumours from MSH2 mutation carriers show loss of MSH2 expression but many tumours from MLH1 mutation carriers exhibit weak positive MLH1 staining
    Mangold, E
    Pagenstecher, C
    Friedl, W
    Fischer, HP
    Merkelbach-Bruse, S
    Ohlendorf, M
    Friedrichs, N
    Aretz, S
    Buettner, R
    Propping, P
    Mathiak, M
    JOURNAL OF PATHOLOGY, 2005, 207 (04): : 385 - 395
  • [7] Germ line MLH1 and MSH2 mutations in Taiwanese Lynch syndrome families: characterization of a founder genomic mutation in the MLH1 gene
    Tang, R.
    Hsiung, C.
    Wang, J-Y
    Lai, C-H
    Chien, H-T
    Chiu, L-L
    Liu, C-T
    Chen, H-H
    Wang, H-M
    Chen, S-X
    Hsieh, L-L
    CLINICAL GENETICS, 2009, 75 (04) : 334 - 345
  • [8] Polymorphisms of MLH1 and MSH2 genes and the risk of lung cancer among never smokers
    Lo, Yen-Li
    Hsiao, Chin-Fu
    Jou, Yuh-Shan
    Chang, Gee-Chen
    Tsai, Ying-Huang
    Su, Wu-Chou
    Chen, Kuan-Yu
    Chen, Yuh-Min
    Huang, Ming-Shyan
    Hsieh, Wan-Shan
    Chen, Chien-Jen
    Hsiung, Chao A.
    LUNG CANCER, 2011, 72 (03) : 280 - 286
  • [9] Partial duplications of the MSH2 and MLH1 genes in hereditary nonpolyposis colorectal cancer
    Baert-Desurmont, Stephanie
    Buisine, Marie-Pierre
    Bessenay, Emilie
    Frerot, Stephanie
    Lovecchio, Tonio
    Martin, Cosette
    Olschwang, Sylviane
    Wang, Qing
    Frebourg, Thierry
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2007, 15 (03) : 383 - 386
  • [10] The First Molecular Screening of MLH1 and MSH2 Genes in Moroccan Colorectal Cancer Patients Shows a Relatively High Mutational Prevalence
    Zahra Moufid, Fatima
    Bouguenouch, Laila
    El Bouchikhi, Ihssane
    Chbani, Laila
    Iraqui Houssaini, Mohamed
    Sekal, Mohamed
    Belhassan, Khadija
    Bennani, Bahia
    Ouldim, Karim
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2018, 22 (08) : 492 - 497